Artia Global Partners LP Amarin Corp Plcuk Transaction History
Artia Global Partners LP
- $280 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding AMRN
# of Institutions
181Shares Held
68.6MCall Options Held
192KPut Options Held
78.1K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.69 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.51 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...